Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Differences between men and women in the use of preventive medications following a major cardiovascular event: Australian prospective cohort study.

Tytuł :
Differences between men and women in the use of preventive medications following a major cardiovascular event: Australian prospective cohort study.
Autorzy :
Barrett E; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, 62 Mills Road, Acton, ACT 2601 Australia.
Paige E; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, 62 Mills Road, Acton, ACT 2601 Australia.
Welsh J; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, 62 Mills Road, Acton, ACT 2601 Australia.
Korda RJ; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, 62 Mills Road, Acton, ACT 2601 Australia.
Joshy G; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, 62 Mills Road, Acton, ACT 2601 Australia.
Martin M; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, 62 Mills Road, Acton, ACT 2601 Australia.
Banks E; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, 62 Mills Road, Acton, ACT 2601 Australia.; The Sax Institute, 13/235 Jones St, Ultimo, NSW 2007, Australia.
Pokaż więcej
Źródło :
Preventive medicine reports [Prev Med Rep] 2021 Mar 07; Vol. 22, pp. 101342. Date of Electronic Publication: 2021 Mar 07 (Print Publication: 2021).
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Original Publication: [New York, NY] : Elsevier Inc., [2014]-
References :
Int J Epidemiol. 2008 Oct;37(5):941-7. (PMID: 17881411)
Med J Aust. 2018 Aug 6;209(3):118-123. (PMID: 30025513)
Intern Med J. 2011 Oct;41(10):730-6. (PMID: 21627740)
Lancet. 2018 Nov 10;392(10159):1789-1858. (PMID: 30496104)
J Public Health (Oxf). 2019 Mar 1;41(1):e84-e94. (PMID: 29850883)
Curr Atheroscler Rep. 2016 May;18(5):28. (PMID: 27029220)
Heart. 2017 Apr;103(7):492-498. (PMID: 28249996)
Lancet. 2002 Jul 6;360(9326):2-3. (PMID: 12114031)
Heart Lung Circ. 2016 Sep;25(9):895-951. (PMID: 27476580)
Eur J Prev Cardiol. 2020 Dec;27(19):2348-2350. (PMID: 32013609)
Circulation. 2005 Feb 1;111(4):499-510. (PMID: 15687140)
Heart. 2019 Dec;105(24):1898-1904. (PMID: 31337667)
Lancet. 2018 Nov 10;392(10159):1736-1788. (PMID: 30496103)
Syst Rev. 2019 May 10;8(1):112. (PMID: 31077247)
Am Heart J. 2013 May;165(5):665-78, 678.e1. (PMID: 23622903)
Heart. 2014 Aug;100(16):1281-8. (PMID: 24914060)
Med J Aust. 2006 Apr 17;184(S8):S1-S32. (PMID: 16618231)
Circulation. 2011 Nov 8;124(19):2145-54. (PMID: 22064958)
BMC Med Res Methodol. 2010 Apr 01;10:26. (PMID: 20356408)
Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):498-503. (PMID: 21450654)
Med J Aust. 2016 May 2;204(8):320. (PMID: 27125809)
Int J Epidemiol. 2013 Aug;42(4):1012-4. (PMID: 24062287)
Heart. 2005 May;91(5):630-4. (PMID: 15831649)
Am J Epidemiol. 2004 Apr 1;159(7):702-6. (PMID: 15033648)
Curr Atheroscler Rep. 2016 Nov;18(11):63. (PMID: 27696318)
Heart Lung Circ. 2021 Jan;30(1):121-127. (PMID: 32888821)
Intern Med J. 2018 May;48(5):541-549. (PMID: 29345403)
Contributed Indexing :
Keywords: Cardiovascular disease; Medication use; Myocardial infarction; Prevention; Sex differences; Stroke
Entry Date(s) :
Date Created: 20210329 Latest Revision: 20210330
Update Code :
20210330
PubMed Central ID :
PMC7985714
DOI :
10.1016/j.pmedr.2021.101342
PMID :
33777665
Czasopismo naukowe
Most cardiovascular disease (CVD) events can be prevented with appropriate risk management. Existing evidence suggests women are less likely than men to receive guideline-recommended medications, however data on sex-differences in preventive medication use following a CVD event are lacking. Relative risks (RRs) comparing use of blood pressure- and lipid-lowering medications in men and women at 3-, 6-, 9- and 12-months following hospitalisation for myocardial infarction (MI) or stroke from 2012 to 2017 were quantified using linked data from 8,278 participants enrolled in the Australian 45 and Up Study. Overall, 51% of women and 58% of men were using both blood-pressure- and lipid-lowering medications three months after a MI or stroke event, decreasing to 48% and 53%, respectively, at 12 months after an event. Adjusting for potential confounders, women were 9% less likely than men (RR = 0.91 [95% CI: 0.87, 0.95]) to be using both medications and 19% more likely (RR = 1.19 [95% CI: 1.07, 1.32]) to use neither medication three months after a MI or stroke event. At the 12-month mark, women were 8% less likely (RR = 0.92 [95% CI: 0.88, 0.97]) to be using both medications and 14% more likely (RR = 1.14 [95% CI: 1.03, 1.26]) to use neither medication. Women were consistently less likely to use both preventive medications and more likely to use neither medication at each follow-up time point. Overall, there were major shortfalls in basic preventive medication use post-CVD event and sex disparities are likely to further jeopardise efforts to reduce CVD events in the community.
(© 2021 The Authors.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies